Skip to content
Home/Companies/Pharma/Royalty Pharma
Royalty Pharma

Royalty Pharma

Pharma·US·Active
Entry
–
Hold
–
Status
Active

Who owns Royalty Pharma?

Royalty Pharma is currently owned by General Atlantic through General Atlantic (2020 vintage).

Hand-verified · updated 2026-04-21

General Atlantic
Investor
General Atlantic
General Atlantic · 2020 · Growth

Key facts

HQUnited States
SectorPharma
Websitewww.royaltypharma.com

More from General Atlantic

Other portfolio companies in the same fund.

58.com
Active
E-commerceChina
A-Max
A-Max
Active
Business ServicesUS
Acko
Active
TMTIndia
Adagene
Active
BiotechChina
Aimbridge Hospitality
Aimbridge Hospitality
Active
Business ServicesUS
AKQA
AKQA
Active
TMTUK

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
iNova
iNova
Exited 2021
The Carlyle GroupAustralia
to
Track Royalty Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Royalty Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Royalty Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue